PL1954281T3 - Sposób leczenia raka - Google Patents

Sposób leczenia raka

Info

Publication number: PL1954281T3
Authority: PL; Poland
Prior art keywords: treatment method; cancer treatment; cancer; administration; relates
Prior art date: 2005-11-29

Application number

PL06838636T

Other languages

English (en)

Inventor

Arundathy Nirmalini Pandite

Bonnie F Whitehead

Peter T C Ho

Albert Benjamin Suttle

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-11-29

Filing date

2006-11-29

Publication date

2011-07-29

2006-11-29 Application filed by Novartis Ag filed Critical Novartis Ag

2011-07-29 Publication of PL1954281T3 publication Critical patent/PL1954281T3/pl

Links

206010028980 Neoplasm Diseases 0.000 title abstract 4
201000011510 cancer Diseases 0.000 title abstract 4
241000124008 Mammalia Species 0.000 abstract 1
208000024770 Thyroid neoplasm Diseases 0.000 abstract 1
CUIHSIWYWATEQL-UHFFFAOYSA-N pazopanib Chemical compound C1=CC2=C(C)N(C)N=C2C=C1N(C)C(N=1)=CC=NC=1NC1=CC=C(C)C(S(N)(=O)=O)=C1 CUIHSIWYWATEQL-UHFFFAOYSA-N 0.000 abstract 1
229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 abstract 1
150000003230 pyrimidines Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1
201000002510 thyroid cancer Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Plural Heterocyclic Compounds (AREA)
Steroid Compounds (AREA)

PL06838636T 2005-11-29 2006-11-29 Sposób leczenia raka PL1954281T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US74030805P	2005-11-29	2005-11-29
EP06838636A EP1954281B1 (en)	2005-11-29	2006-11-29	Cancer treatment method
PCT/US2006/045777 WO2007064753A2 (en)	2005-11-29	2006-11-29	Cancer treatment method

Publications (1)

Publication Number	Publication Date
PL1954281T3 true PL1954281T3 (pl)	2011-07-29

Family

ID=37847172

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL06838636T PL1954281T3 (pl)	2005-11-29	2006-11-29	Sposób leczenia raka

Country Status (12)

Country	Link
US (1)	US20090005406A1 (pl)
EP (2)	EP2380572A1 (pl)
JP (1)	JP2009517397A (pl)
AT (1)	ATE500831T1 (pl)
CY (1)	CY1111390T1 (pl)
DE (1)	DE602006020611D1 (pl)
DK (1)	DK1954281T3 (pl)
ES (1)	ES2359517T3 (pl)
HR (1)	HRP20110244T1 (pl)
PL (1)	PL1954281T3 (pl)
SI (1)	SI1954281T1 (pl)
WO (1)	WO2007064753A2 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2058307A1 (en)	2007-11-12	2009-05-13	Cellzome Ag	Methods for the identification of JAK kinase interacting molecules and for the purification of JAK kinases
US20120197019A1 (en) *	2009-10-23	2012-08-02	Dharmesh Surendra Bhanushali	Compositions and processes
WO2011058179A1 (en)	2009-11-16	2011-05-19	Ratiopharm Gmbh	5- (4- (n- (2, 3 -dimethyl- 2h- indazol- 6 -yl) -n-methylamino) pyrimidin- 2 -ylamino) -2 -methylbenzenesulfonamide
WO2011069053A1 (en)	2009-12-04	2011-06-09	Teva Pharmaceutical Industries Ltd.	Process for the preparation of pazopanip hcl and crystalline forms of pazopanib hcl
BR112013009701A2 (pt)	2010-10-27	2016-07-19	Novartis Ag	regimes de dosagem para o tratamento de doença vascular ocular
CA2852912A1 (en) *	2011-10-31	2013-05-10	Glaxosmithkline Intellectual Property Limited	Pazopanib formulation
AU2013221298A1 (en) *	2012-02-17	2014-08-28	Pharmacyclics Llc	Combinations of histone deacetylase inhibitor and pazopanib and uses thereof
CN103319410B (zh) *	2012-03-22	2016-04-06	天津药物研究院	一种吲唑化合物的合成方法
CN103232443B (zh) *	2013-02-01	2014-12-10	天津药物研究院	一种吲唑衍生物的晶型及其制备和用途
WO2015068175A2 (en)	2013-11-05	2015-05-14	Laurus Labs Private Limited	An improved process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof
CN110878089A (zh) *	2018-09-05	2020-03-13	江苏豪森药业集团有限公司	一种盐酸帕唑帕尼的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR0116452A (pt) *	2000-12-21	2003-09-30	Glaxo Group Ltd	Composto, composição farmacêutica, uso de um composto
DE60203260T2 (de)	2001-01-16	2006-02-02	Glaxo Group Ltd., Greenford	Pharmazeutische kombination, die ein 4-chinazolinamin und paclitaxel, carboplatin oder vinorelbin enthält, zur behandlung von krebs
CA2489648A1 (en)	2002-06-17	2003-12-24	Smithkline Beecham Corporation	Chemical process
JP2007532658A (ja) *	2004-04-16	2007-11-15	スミスクラインビーチャムコーポレーション	がんの治療方法

2006
- 2006-11-29 HR HR20110244T patent/HRP20110244T1/hr unknown
- 2006-11-29 ES ES06838636T patent/ES2359517T3/es active Active
- 2006-11-29 EP EP10194774A patent/EP2380572A1/en not_active Withdrawn
- 2006-11-29 EP EP06838636A patent/EP1954281B1/en not_active Not-in-force
- 2006-11-29 WO PCT/US2006/045777 patent/WO2007064753A2/en not_active Ceased
- 2006-11-29 PL PL06838636T patent/PL1954281T3/pl unknown
- 2006-11-29 SI SI200631005T patent/SI1954281T1/sl unknown
- 2006-11-29 US US12/094,687 patent/US20090005406A1/en not_active Abandoned
- 2006-11-29 DK DK06838636.6T patent/DK1954281T3/da active
- 2006-11-29 AT AT06838636T patent/ATE500831T1/de active
- 2006-11-29 DE DE602006020611T patent/DE602006020611D1/de active Active
- 2006-11-29 JP JP2008542487A patent/JP2009517397A/ja active Pending
2011
- 2011-04-18 CY CY20111100387T patent/CY1111390T1/el unknown

Also Published As

Publication number	Publication date
DE602006020611D1 (de)	2011-04-21
WO2007064753A3 (en)	2007-11-29
ATE500831T1 (de)	2011-03-15
CY1111390T1 (el)	2015-08-05
EP2380572A1 (en)	2011-10-26
ES2359517T3 (es)	2011-05-24
EP1954281B1 (en)	2011-03-09
US20090005406A1 (en)	2009-01-01
SI1954281T1 (sl)	2011-06-30
WO2007064753A2 (en)	2007-06-07
EP1954281A2 (en)	2008-08-13
HRP20110244T1 (hr)	2011-04-30
DK1954281T3 (da)	2011-05-16
JP2009517397A (ja)	2009-04-30

Similar Documents

Publication	Publication Date	Title
CY1111390T1 (el)	2015-08-05	Μεθοδος θεραπευτικης αγωγης καρκινου
EA200970575A1 (ru)	2009-12-30	Соединения на основе 4-фенил-6-(2,2,2-трифтор-1-фенилэтокси)пиримидина и способы их применения
MY144750A (en)	2011-10-31	Treatment method
NZ594385A (en)	2013-02-22	Aminopyrimidines useful as kinase inhibitors
MXPA05011643A (es)	2005-12-15	5,7-diaminopirazolo[4,3-d]pirimidinas en el tratamiento de hipertension.
DE60332137D1 (en)	2010-05-27	Cyclohexyl-sulphone als gamma-sekretase-inhibitoren
NO20081592L (no)	2008-05-23	Dipeptidylpeptidaseinhibitorer for behandling av diabetes
MXPA05012323A (es)	2006-01-30	Sulfonamidas ciclicas para la inhibicion de gama-secretasa.
PL406680A1 (pl)	2014-03-31	Inhibitory kinaz tyrozynowych
GB0117645D0 (en)	2001-09-12	Therapeutic stratergies for prevention and treatment of alzheimers disease
IS7857A (is)	2005-08-18	Setnar pýrróló-pýrasól afleiður sem kínasa hindrar
ATE365733T1 (de)	2007-07-15	Zusammensetzungen brauchbar als protein-kinase- inhibitoren
WO2007143483A3 (en)	2008-02-07	Combination of pazopanib and lapatinib for treating cancer
IS8485A (is)	2006-05-26	Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki
DK1926729T3 (da)	2012-03-19	Benzothiazolcyclobutylaminderivater og deres anvendelse som histamin-3-receptorligander
GEP20105031B (en)	2010-06-25	Stable emulsion composition
EA200900034A1 (ru)	2009-06-30	Применение ингибитора р38 киназы для лечения психиатрических расстройств
TW200730507A (en)	2007-08-16	Pyrimidine derivatives for the treatment of abnormal cell growth
DK1684763T3 (da)	2008-09-01	6-Aryl-7-halogen-imidazo(1,2-a)pyrimidiner som anticancermiddel
UA80871C2 (en)	2007-11-12	5,7-diaminopyrazolo[4,3-d]pyrimidines useful in the treatment of hypertension
TW200626588A (en)	2006-08-01	(Arylamidoaryl)cyanoguanidine compounds
PL1865961T3 (pl)	2012-07-31	Famciklowir do leczenia nawracającej opryszczki wargowej z zastosowaniem leczenia jednodniowego
GB0807094D0 (en)	2008-05-21	4,4-dimethylpiperidine-2, 6-dione derivatives for use in the treatment of hypertension
TW200505836A (en)	2005-02-16	Cyclic sulfonamides for inhibition of gamma-secretase
JO3254B1 (ar)	2018-09-16	مثبطات ببتيداز ثنائي ببتيديل لمعالجة مرض السكر